1. Home
  2. MBIN vs ATAI Comparison

MBIN vs ATAI Comparison

Compare MBIN & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Merchants Bancorp

MBIN

Merchants Bancorp

HOLD

Current Price

$53.42

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo ATAI Life Sciences N.V.

ATAI

ATAI Life Sciences N.V.

HOLD

Current Price

$7.42

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBIN
ATAI
Founded
1990
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.7B
IPO Year
2017
2025

Fundamental Metrics

Financial Performance
Metric
MBIN
ATAI
Price
$53.42
$7.42
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$43.67
$15.88
AVG Volume (30 Days)
147.0K
8.7M
Earning Date
04-28-2026
05-11-2026
Dividend Yield
0.89%
N/A
EPS Growth
N/A
N/A
EPS
2.73
N/A
Revenue
N/A
$4,089,000.00
Revenue This Year
$31.76
N/A
Revenue Next Year
$3.73
N/A
P/E Ratio
$19.60
N/A
Revenue Growth
N/A
1227.60
52 Week Low
$30.37
$3.27
52 Week High
$56.87
$7.37

Technical Indicators

Market Signals
Indicator
MBIN
ATAI
Relative Strength Index (RSI) 52.83 N/A
Support Level $52.89 N/A
Resistance Level $56.87 N/A
Average True Range (ATR) 1.23 0.00
MACD -0.29 0.00
Stochastic Oscillator 9.66 0.00

Price Performance

Historical Comparison
MBIN
ATAI

About MBIN Merchants Bancorp

Merchants Bancorp is a United States-based bank holding company operating multiple lines of business focused on FHA multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. Its segments include Multi-family Mortgage Banking, which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing, which offers mortgage warehouse financing, commercial loans and deposit services; and the Banking segment, which generates maximum revenue and provides portfolio lending for multi-family and healthcare facility loans, residential mortgage banking, agricultural lending, SBA lending and community banking.

About ATAI ATAI Life Sciences N.V.

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.

Share on Social Networks: